Article Text

Download PDFPDF

Warfarin: a case history in pharmacogenetics
  1. A M Hall,
  2. M R Wilkins
  1. Experimental Medicine & Toxicology, Imperial College, Hammersmith Hospital, London, UK
  1. Correspondence to:
    Professor Martin R Wilkins
    Experimental Medicine & Toxicology, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK; m.wilkinsimperial.ac.uk

Abstract

Both hereditary and environmental factors contribute to inter-individual variability in drug response. The considerable interest in the role of genes has to be balanced with the contribution of external influences. Warfarin provides a useful case study of the need to integrate both genetic and non-genetic information when selecting the right dose for a patient. This article discusses the latest data on genotype and warfarin sensitivity and the efforts to incorporate this information into normograms. Exploring the genetics of warfarin response will lead not only to safer prescribing but elucidate the mechanism of action of warfarin and enable the development of new anticoagulant drugs.

  • genetic susceptibility
  • pharmacogenetics
  • warfarin
View Full Text

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.